Arthrex, Inc.
  • Events Calendar
  • 0 0

Cellular Products

For many years autologous blood product, or blood components derived from the patient and then delivered to a point of care, have created growing interest for use in a number of orthopedic procedures. The aim of technologies like ACP (Autologous Conditioned Plasma) is to provide physicians with concentrated levels of growth factors for use at the point of care. Increased levels of growth factors improve signaling and recruitment of cells to an injury site and optimize the environment for healing. 

You have 0 items in your cart.

Use the checkboxes below to add items.

Get more help on how to request a quote or surgical evaluation